Close Menu

The Montreal Proteomics Network plans by the end of the year to lay off 45 of 63 scientists, or more than 70 percent of its GC-funded research staff, who are paid through a grant from Genome Canada because the funding has run out, ProteoMonitor has learned.

MPN’s operational costs have been covered by a three-and-a-half-year, CA$13 million ($11 million) grant from Genome Canada that will expire in March. But in order to keep going through 2005, the network will have to lay off staff sooner than that.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.